Michael Hill Founder Steps Down Amid Health Battle

Highlights:

• Sir Michael Hill temporarily steps down from Michael Hill International Limited (NZX: MHI) board for cancer treatment.
• Andrea Slingsby appointed as alternate director, bringing strong governance and retail experience.
• Board expresses confidence in continued operational stability during the leadership transition.

Leadership Change Announced

Michael Hill International Limited (NZX: MHI) has announced that its founder and namesake, Sir Michael Hill, will temporarily step away from the board as he undergoes cancer treatment. The announcement was made via a shareholder update on Monday, with the company confirming that experienced executive Andrea Slingsby will serve as his alternate director during this period.

Andrea Slingsby Brings Deep Retail Experience

At the time of writing, Andrea Slingsby brings with her a wealth of leadership experience across global retail and advisory sectors. Her previous tenure with Michael Hill International included serving as interim Chief People Officer between August 2018 and October 2019. The company highlighted her strong background in governance, consulting, and strategic advisory roles, reinforcing confidence in a smooth leadership transition during Sir Michael’s absence.

Focus on Stability During Transition

Sir Michael Hill has been a central figure in the company’s growth since its inception, building the jewellery brand into a well-known retail chain across New Zealand, Australia, and Canada. While stepping back for health reasons, the founder expressed his continued belief in the company’s direction and leadership.The board acknowledged the impact of his leadership and wished him well in his recovery. They also reassured shareholders that Slingsby’s appointment will support business continuity and uphold the company’s strategic momentum in the months ahead.This leadership change comes at a critical time as Michael Hill International continues to navigate shifting consumer demand and evolving retail trends globally. Investors will likely be watching closely for any updates on Sir Michael's recovery and the company’s performance under Slingsby's interim directorship.

Disclaimer for Kapitales Research

The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com